Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy

NCT04039516 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Carcinoid Heart Disease
Carcinoid Syndrome
Carcinoid Tumor

Interventions

DRUG: Lutathera

Sponsor

King's College Hospital NHS Trust

Collaborators

[object Object]